AbbVie One-Year Fellowship: U.S. Medical Affairs Immunology
November 22, 2021
Address
North Chicago, IL 60064
Calendar
Download iCal FileThe AbbVie Pharmaceutical Industry Fellowship Program provides a unique opportunity with a field leader, preparing PharmDs and PhDs for successful careers in industry. Candidates are encouraged to review the application requirements and deadlines, as admission into the program is competitive.
Requirements for Eligibility
A successful candidate must be a Pharm.D. graduate from an ACPE accredited institution. Substantial background knowledge in a related field is a plus. All candidates must be authorized to work in the United States on a permanent basis without requiring sponsorship.
Available Positions:*
• Immunology/Gastroenterology Fellow
• Immunology/Rheumatology Fellow
• Immunology/Dermatology Fellow
• Medical Payer Strategy Fellow (Cross Therapeutic)
*Subject to change
Admission
To apply, send the following materials to usmafellowships@abbvie.com
• Letter of intent
• Two references with email addresses
• Two letters of recommendation sent via email from each of the two references directly
• Curriculum Vitae (CV)
• Unofficial pharmacy school transcript
• Any additional materials that the candidate feels would be useful to the interview committee
Deadline
Candidates are required to submit all required application materials by November 22, 2021.*
*Interviews will be conducted on a rolling basis and early application is strongly encouraged
Contact Information
Kelly Chan, Pharm.D. Post-Doctoral Fellow, U.S. Medical Affairs, Immunology-Rheumatology
Email: kelly.chan@abbvie.com
Tamica Collins, Ph.D. Post-Doctoral Fellow, U.S. Medical Affairs, Immunology-Gastroenterology
Email: tamica.collins@abbvie.com
Chibuzo Obi, Pharm.D. Post-Doctoral Fellow, U.S. Medical Affairs, Immunology-Dermatology
Email: chibuzo.obi@abbvie.com
Kayla Judson, Pharm.D. Post-Doctoral Fellow, U.S. Medical Affairs, Immunology-Medical Payer Strategy
Email: kayla.judson@abbvie.com
Date posted
Sep 10, 2021
Date updated
Sep 14, 2021